$158,000 ALS drug pulled from market after failing in large clinical trial
The drug is now unavailable to new patients; its maker to lay off 70% of employees.
@arstechnica Maybe they shouldn't have been allowed to shake down patients before they could prove that it worked?
@sepdroid @arstechnica Stop. The. Presses.
@arstechnica Why was it for sale before passing a large clinical trial?
@Magess @arstechnica
Because they needed to pay 70% of their employees, obviously!
@Magess Because nothing can help those patients and the hint of promise is enough to say "why not?" whole hoping for the best